Oroxylum indicum, an ingredient also known by the name midnight horror, may help alleviate symptoms of hyperglycemia associated with diabetes.
Sami-Sabinsa Group (East Windsor, NJ) has acquired the exclusive global marketing rights for two patents on Oroxylum indicum, an ingredient also known by the name midnight horror, and that may help alleviate symptoms of hyperglycemia associated with diabetes. Sabinsa obtained the patent rights from India R&D lab the Indian Institute of Chemical Technology (CSIR; Hyderabad, India).
Sabinsa has acquired two patents on Oroxylum indicum. The first (European patent #EP1986670) relates to use of the botanical’s bioactive molecules oroxylin A, baicalein, and chrysin as alpha-glucosidase inhibitors. The second patent (U.S. patent #US7855200) relates to the use of those same constituents from Oroxylum indicum for treating gastric ulcers induced by aspirin.
Traditional Ayurvedic medicinal uses for Oroxylum indicum are varied and include curing gastic ulcer; applying a paste made from the bark in cases of mouth cancer, scabies, and other skin diseases; using the seed for relief of tonsil pain; and using the paste to kill maggots in animals.